Skip to Content

In the News

Dr. Bucshon’s Statement on Food and Drug Administration Decision to Grant Emergency Use Authorization for Pfizer’s COVID-19 Vaccine

(Washington, D.C.) – 
Congressman Larry Bucshon, M.D. (IN-08) released the following statement after the Food and Drug Administration (FDA) granted an emergency use authorization (EUA) to Pfizer's COVID-19 vaccine for individuals 16 years and older:

Nearly a year ago, a novel virus emerged from China that spread across the world. Our economy has been greatly impacted and far too many Americans have lost their lives. Thankfully, President Trump acted decisively in the spring to initiate Operation Warp Speed to bring together leading scientists, infectious disease experts, and pharmaceutical companies to expedite the process of readying a vaccine for COVID-19, while maintaining the vigorous scientific review and approval process standards set by the FDA, in record time. Now, less than a year later, the FDA has granted emergency use authorization for Pfizer’s COVID-19 vaccine. I am confident in the science behind this vaccine – both its efficacy, and its safety – and I encourage all eligible Americans to get the vaccine at the appropriate time. 

 “While states and the federal government coordinate to distribute the vaccine with the help of our military, it is important to continue to practice guidelines issued by the CDC to prevent the spread of COVID-19. It has been a long road to get to this moment and it will take patience and perseverance to see this through the end but there is light at the end of the tunnel.”